A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common malignant tumor that seriously affects human health. Previous studies have indicated that abnormal levels of glycosylation promote progression and poor prognosis of lung cancer. Thus, the present study aimed to explore the prognostic signatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jin-xiao, Chen, Qian, Gao, Wei, Chen, Da, Qian, Xin-yu, Bi, Jin-qiao, Lin, Xing-chen, Han, Bing-bing, Liu, Jin-shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793550/
https://www.ncbi.nlm.nih.gov/pubmed/36575396
http://dx.doi.org/10.1186/s12859-022-05109-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793550/
https://www.ncbi.nlm.nih.gov/pubmed/36575396
http://dx.doi.org/10.1186/s12859-022-05109-8

Ejemplares similares